A Phase III Clinical Trial to Evaluate the Efficacy and Safety of the Live Attenuated Varicella Vaccine
Clinical trial NCT05669625 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05669625
- Sponsor
- China National Biotec Group Company Limited
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-26
- Primary completion
- 2024-04-14
- Enrollment
- 12440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.